 | • レポートコード：GIR-105X04875 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、106ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ダクラタスビルのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ダクラタスビルの種類別市場規模（30mg錠、60mg錠）、用途別市場規模（C型肝炎ウイルス（HCV）遺伝子型1、C型肝炎ウイルス（HCV）遺伝子型3、C型肝炎ウイルス（HCV）遺伝子型4）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ダクラタスビルの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Bristol-Myers Squibb、Natco Pharma、Zydus Cadila、Hetero Drugs、Dr Reddy's Laboratories、Cipla、Mylan、Abbott、Emcure Pharmaceuticals、Torrent Pharmaceuticals、Biocon ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：30mg錠、60mg錠 ・用途別分析2016年-2026年：C型肝炎ウイルス（HCV）遺伝子型1、C型肝炎ウイルス（HCV）遺伝子型3、C型肝炎ウイルス（HCV）遺伝子型4 ・ダクラタスビルの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ダクラタスビルのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ダクラタスビルのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ダクラタスビルの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ダクラタスビルの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Daclatasvir market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Daclatasvir size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Daclatasvir market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Daclatasvir market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
30mg Tables
60mg Tables
Market segment by Application can be divided into
Hepatitis C Virus (HCV) Genotype 1
Hepatitis C Virus (HCV) Genotype 3
Hepatitis C Virus (HCV) Genotype 4
The key market players for global Daclatasvir market are listed below:
Bristol-Myers Squibb
Natco Pharma
Zydus Cadila
Hetero Drugs
Dr Reddy’s Laboratories
Cipla
Mylan
Abbott
Emcure Pharmaceuticals
Torrent Pharmaceuticals
Biocon
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Daclatasvir Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Daclatasvir Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 30mg Tables
1.2.3 60mg Tables
1.3 Market Analysis by Application
1.3.1 Overview: Global Daclatasvir Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hepatitis C Virus (HCV) Genotype 1
1.3.3 Hepatitis C Virus (HCV) Genotype 3
1.3.4 Hepatitis C Virus (HCV) Genotype 4
1.4 Global Daclatasvir Market Size & Forecast
1.4.1 Global Daclatasvir Sales in Value (2016-2026))
1.4.2 Global Daclatasvir Sales in Volume (2016-2026)
1.4.3 Global Daclatasvir Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Daclatasvir Production Capacity Analysis
1.5.1 Global Daclatasvir Total Production Capacity (2016-2026)
1.5.2 Global Daclatasvir Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Daclatasvir Market Drivers
1.6.2 Daclatasvir Market Restraints
1.6.3 Daclatasvir Trends Analysis
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Bristol-Myers Squibb Details
2.1.2 Bristol-Myers Squibb Major Business
2.1.3 Bristol-Myers Squibb Daclatasvir Product and Services
2.1.4 Bristol-Myers Squibb Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Natco Pharma
2.2.1 Natco Pharma Details
2.2.2 Natco Pharma Major Business
2.2.3 Natco Pharma Daclatasvir Product and Services
2.2.4 Natco Pharma Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila Daclatasvir Product and Services
2.3.4 Zydus Cadila Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Hetero Drugs
2.4.1 Hetero Drugs Details
2.4.2 Hetero Drugs Major Business
2.4.3 Hetero Drugs Daclatasvir Product and Services
2.4.4 Hetero Drugs Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Dr Reddy’s Laboratories
2.5.1 Dr Reddy’s Laboratories Details
2.5.2 Dr Reddy’s Laboratories Major Business
2.5.3 Dr Reddy’s Laboratories Daclatasvir Product and Services
2.5.4 Dr Reddy’s Laboratories Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Cipla
2.6.1 Cipla Details
2.6.2 Cipla Major Business
2.6.3 Cipla Daclatasvir Product and Services
2.6.4 Cipla Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Mylan
2.7.1 Mylan Details
2.7.2 Mylan Major Business
2.7.3 Mylan Daclatasvir Product and Services
2.7.4 Mylan Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Abbott
2.8.1 Abbott Details
2.8.2 Abbott Major Business
2.8.3 Abbott Daclatasvir Product and Services
2.8.4 Abbott Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Emcure Pharmaceuticals
2.9.1 Emcure Pharmaceuticals Details
2.9.2 Emcure Pharmaceuticals Major Business
2.9.3 Emcure Pharmaceuticals Daclatasvir Product and Services
2.9.4 Emcure Pharmaceuticals Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Torrent Pharmaceuticals
2.10.1 Torrent Pharmaceuticals Details
2.10.2 Torrent Pharmaceuticals Major Business
2.10.3 Torrent Pharmaceuticals Daclatasvir Product and Services
2.10.4 Torrent Pharmaceuticals Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 Biocon
2.11.1 Biocon Details
2.11.2 Biocon Major Business
2.11.3 Biocon Daclatasvir Product and Services
2.11.4 Biocon Daclatasvir Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Daclatasvir Sales by Manufacturer
3.1 Global Daclatasvir Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Daclatasvir Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Daclatasvir
3.4 Market Concentration Rate
3.4.1 Top 3 Daclatasvir Manufacturer Market Share
3.4.2 Top 6 Daclatasvir Manufacturer Market Share
3.5 Global Daclatasvir Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Daclatasvir Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Daclatasvir Market Size by Region
4.1.1 Global Daclatasvir Sales in Volume by Region (2016-2026)
4.1.2 Global Daclatasvir Revenue by Region (2016-2026)
4.2 North America Daclatasvir Revenue (2016-2026)
4.3 Europe Daclatasvir Revenue (2016-2026)
4.4 Asia-Pacific Daclatasvir Revenue (2016-2026)
4.5 South America Daclatasvir Revenue (2016-2026)
4.6 Middle East and Africa Daclatasvir Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Daclatasvir Sales in Volume by Type (2016-2026)
5.2 Global Daclatasvir Revenue by Type (2016-2026)
5.3 Global Daclatasvir Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Daclatasvir Sales in Volume by Application (2016-2026)
6.2 Global Daclatasvir Revenue by Application (2016-2026)
6.3 Global Daclatasvir Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Daclatasvir Sales by Type (2016-2026)
7.2 North America Daclatasvir Sales by Application (2016-2026)
7.3 North America Daclatasvir Market Size by Country
7.3.1 North America Daclatasvir Sales in Volume by Country (2016-2026)
7.3.2 North America Daclatasvir Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Daclatasvir Sales by Type (2016-2026)
8.2 Europe Daclatasvir Sales by Application (2016-2026)
8.3 Europe Daclatasvir Market Size by Country
8.3.1 Europe Daclatasvir Sales in Volume by Country (2016-2026)
8.3.2 Europe Daclatasvir Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Daclatasvir Sales by Type (2016-2026)
9.2 Asia-Pacific Daclatasvir Sales by Application (2016-2026)
9.3 Asia-Pacific Daclatasvir Market Size by Region
9.3.1 Asia-Pacific Daclatasvir Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Daclatasvir Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Daclatasvir Sales by Type (2016-2026)
10.2 South America Daclatasvir Sales by Application (2016-2026)
10.3 South America Daclatasvir Market Size by Country
10.3.1 South America Daclatasvir Sales in Volume by Country (2016-2026)
10.3.2 South America Daclatasvir Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Daclatasvir Sales by Type (2016-2026)
11.2 Middle East & Africa Daclatasvir Sales by Application (2016-2026)
11.3 Middle East & Africa Daclatasvir Market Size by Country
11.3.1 Middle East & Africa Daclatasvir Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Daclatasvir Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Daclatasvir Typical Distributors
12.3 Daclatasvir Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Daclatasvir Revenue by Type, (USD Million), 2021-2026
Table 2. Global Daclatasvir Revenue by Application, (USD Million), 2021-2026
Table 3. Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 4. Bristol-Myers Squibb Major Business
Table 5. Bristol-Myers Squibb Daclatasvir Product and Services
Table 6. Bristol-Myers Squibb Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 8. Natco Pharma Major Business
Table 9. Natco Pharma Daclatasvir Product and Services
Table 10. Natco Pharma Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 12. Zydus Cadila Major Business
Table 13. Zydus Cadila Daclatasvir Product and Services
Table 14. Zydus Cadila Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Hetero Drugs Basic Information, Manufacturing Base and Competitors
Table 16. Hetero Drugs Major Business
Table 17. Hetero Drugs Daclatasvir Product and Services
Table 18. Hetero Drugs Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Dr Reddy's Laboratories Basic Information, Manufacturing Base and Competitors
Table 20. Dr Reddy's Laboratories Major Business
Table 21. Dr Reddy's Laboratories Daclatasvir Product and Services
Table 22. Dr Reddy's Laboratories Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Cipla Basic Information, Manufacturing Base and Competitors
Table 24. Cipla Major Business
Table 25. Cipla Daclatasvir Product and Services
Table 26. Cipla Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Mylan Basic Information, Manufacturing Base and Competitors
Table 28. Mylan Major Business
Table 29. Mylan Daclatasvir Product and Services
Table 30. Mylan Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Abbott Basic Information, Manufacturing Base and Competitors
Table 32. Abbott Major Business
Table 33. Abbott Daclatasvir Product and Services
Table 34. Abbott Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Emcure Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 36. Emcure Pharmaceuticals Major Business
Table 37. Emcure Pharmaceuticals Daclatasvir Product and Services
Table 38. Emcure Pharmaceuticals Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Torrent Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Torrent Pharmaceuticals Major Business
Table 41. Torrent Pharmaceuticals Daclatasvir Product and Services
Table 42. Torrent Pharmaceuticals Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Biocon Basic Information, Manufacturing Base and Competitors
Table 44. Biocon Major Business
Table 45. Biocon Daclatasvir Product and Services
Table 46. Biocon Daclatasvir Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Global Daclatasvir Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 48. Global Daclatasvir Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 49. Market Position of Manufacturers in Daclatasvir, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 50. Global Daclatasvir Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 51. Head Office and Daclatasvir Production Site of Key Manufacturer
Table 52. Global Daclatasvir Sales by Region (2016-2021e) & (K Pcs)
Table 53. Global Daclatasvir Sales by Region (2021-2026) & (K Pcs)
Table 54. Global Daclatasvir Revenue by Region (2016-2021e) & (USD Million)
Table 55. Global Daclatasvir Revenue by Region (2021-2026) & (USD Million)
Table 56. Global Daclatasvir Sales by Type (2016-2021e) & (K Pcs)
Table 57. Global Daclatasvir Sales by Type (2021-2026) & (K Pcs)
Table 58. Global Daclatasvir Revenue by Type (2016-2021e) & (USD Million)
Table 59. Global Daclatasvir Revenue by Type (2021-2026) & (USD Million)
Table 60. Global Daclatasvir Price by Type (2016-2021e) & (USD/Pcs)
Table 61. Global Daclatasvir Price by Type (2021-2026) & (USD/Pcs)
Table 62. Global Daclatasvir Sales by Application (2016-2021e) & (K Pcs)
Table 63. Global Daclatasvir Sales by Application (2021-2026) & (K Pcs)
Table 64. Global Daclatasvir Revenue by Application (2016-2021e) & (USD Million)
Table 65. Global Daclatasvir Revenue by Application (2021-2026) & (USD Million)
Table 66. Global Daclatasvir Price by Application (2016-2021e) & (USD/Pcs)
Table 67. Global Daclatasvir Price by Application (2021-2026) & (USD/Pcs)
Table 68. North America Daclatasvir Sales by Country (2016-2021e) & (K Pcs)
Table 69. North America Daclatasvir Sales by Country (2021-2026) & (K Pcs)
Table 70. North America Daclatasvir Revenue by Country (2016-2021e) & (USD Million)
Table 71. North America Daclatasvir Revenue by Country (2021-2026) & (USD Million)
Table 72. North America Daclatasvir Sales by Type (2016-2021e) & (K Pcs)
Table 73. North America Daclatasvir Sales by Type (2021-2026) & (K Pcs)
Table 74. North America Daclatasvir Sales by Application (2016-2021e) & (K Pcs)
Table 75. North America Daclatasvir Sales by Application (2021-2026) & (K Pcs)
Table 76. Europe Daclatasvir Sales by Country (2016-2021e) & (K Pcs)
Table 77. Europe Daclatasvir Sales by Country (2021-2026) & (K Pcs)
Table 78. Europe Daclatasvir Revenue by Country (2016-2021e) & (USD Million)
Table 79. Europe Daclatasvir Revenue by Country (2021-2026) & (USD Million)
Table 80. Europe Daclatasvir Sales by Type (2016-2021e) & (K Pcs)
Table 81. Europe Daclatasvir Sales by Type (2021-2026) & (K Pcs)
Table 82. Europe Daclatasvir Sales by Application (2016-2021e) & (K Pcs)
Table 83. Europe Daclatasvir Sales by Application (2021-2026) & (K Pcs)
Table 84. Asia-Pacific Daclatasvir Sales by Region (2016-2021e) & (K Pcs)
Table 85. Asia-Pacific Daclatasvir Sales by Region (2021-2026) & (K Pcs)
Table 86. Asia-Pacific Daclatasvir Revenue by Region (2016-2021e) & (USD Million)
Table 87. Asia-Pacific Daclatasvir Revenue by Region (2021-2026) & (USD Million)
Table 88. Asia-Pacific Daclatasvir Sales by Type (2016-2021e) & (K Pcs)
Table 89. Asia-Pacific Daclatasvir Sales by Type (2021-2026) & (K Pcs)
Table 90. Asia-Pacific Daclatasvir Sales by Application (2016-2021e) & (K Pcs)
Table 91. Asia-Pacific Daclatasvir Sales by Application (2021-2026) & (K Pcs)
Table 92. South America Daclatasvir Sales by Country (2016-2021e) & (K Pcs)
Table 93. South America Daclatasvir Sales by Country (2021-2026) & (K Pcs)
Table 94. South America Daclatasvir Revenue by Country (2016-2021e) & (USD Million)
Table 95. South America Daclatasvir Revenue by Country (2021-2026) & (USD Million)
Table 96. South America Daclatasvir Sales by Type (2016-2021e) & (K Pcs)
Table 97. South America Daclatasvir Sales by Type (2021-2026) & (K Pcs)
Table 98. South America Daclatasvir Sales by Application (2016-2021e) & (K Pcs)
Table 99. South America Daclatasvir Sales by Application (2021-2026) & (K Pcs)
Table 100. Middle East & Africa Daclatasvir Sales by Country (2016-2021e) & (K Pcs)
Table 101. Middle East & Africa Daclatasvir Sales by Country (2021-2026) & (K Pcs)
Table 102. Middle East & Africa Daclatasvir Revenue by Country (2016-2021e) & (USD Million)
Table 103. Middle East & Africa Daclatasvir Revenue by Country (2021-2026) & (USD Million)
Table 104. Middle East & Africa Daclatasvir Sales by Type (2016-2021e) & (K Pcs)
Table 105. Middle East & Africa Daclatasvir Sales by Type (2021-2026) & (K Pcs)
Table 106. Middle East & Africa Daclatasvir Sales by Application (2016-2021e) & (K Pcs)
Table 107. Middle East & Africa Daclatasvir Sales by Application (2021-2026) & (K Pcs)
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Daclatasvir Typical Distributors
Table 111. Daclatasvir Typical Customers
List of Figures
Figure 1. Daclatasvir Picture
Figure 2. Global Daclatasvir Sales Market Share by Type in 2020
Figure 3. 30mg Tables
Figure 4. 60mg Tables
Figure 5. Global Daclatasvir Sales Market Share by Application in 2020
Figure 6. Hepatitis C Virus (HCV) Genotype 1
Figure 7. Hepatitis C Virus (HCV) Genotype 3
Figure 8. Hepatitis C Virus (HCV) Genotype 4
Figure 9. Global Daclatasvir Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 10. Global Daclatasvir Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Daclatasvir Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Daclatasvir Sales (2016-2026) & (K Pcs)
Figure 31. Global Daclatasvir Production Capacity (2016-2026) & (K Pcs)
Figure 32. Global Daclatasvir Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Daclatasvir Market Drivers
Figure 34. Daclatasvir Market Restraints
Figure 35. Daclatasvir Market Trends
Figure 36. Global Daclatasvir Sales Market Share by Manufacturer in 2020
Figure 37. Global Daclatasvir Revenue Market Share by Manufacturer in 2020
Figure 38. Daclatasvir Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Daclatasvir Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Daclatasvir Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Daclatasvir Sales Market Share by Region (2016-2026)
Figure 42. Global Daclatasvir Revenue Market Share by Region (2016-2026)
Figure 43. North America Daclatasvir Revenue (2016-2026) & (USD Million)
Figure 44. Europe Daclatasvir Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Daclatasvir Revenue (2016-2026) & (USD Million)
Figure 46. South America Daclatasvir Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Daclatasvir Revenue (2016-2026) & (USD Million)
Figure 48. Global Daclatasvir Sales Market Share by Type (2016-2026)
Figure 49. Global Daclatasvir Revenue Market Share by Type (2016-2026)
Figure 50. Global Daclatasvir Price by Type (2016-2026) & (USD/Pcs)
Figure 51. Global Daclatasvir Sales Market Share by Application (2016-2026)
Figure 52. Global Daclatasvir Revenue Market Share by Application (2016-2026)
Figure 53. Global Daclatasvir Price by Application (2016-2026) & (USD/Pcs)
Figure 54. North America Daclatasvir Sales Market Share by Country (2016-2026)
Figure 55. North America Daclatasvir Revenue Market Share by Country (2016-2026)
Figure 56. North America Daclatasvir Sales Market Share by Type (2016-2026)
Figure 57. North America Daclatasvir Sales Market Share by Application (2016-2026)
Figure 58. Europe Daclatasvir Sales Market Share by Country (2016-2026)
Figure 59. Europe Daclatasvir Revenue Market Share by Country (2016-2026)
Figure 60. Europe Daclatasvir Sales Market Share by Type (2016-2026)
Figure 61. Europe Daclatasvir Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Daclatasvir Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Daclatasvir Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Daclatasvir Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Daclatasvir Sales Market Share by Application (2016-2026)
Figure 66. South America Daclatasvir Sales Market Share by Country (2016-2026)
Figure 67. South America Daclatasvir Revenue Market Share by Country (2016-2026)
Figure 68. South America Daclatasvir Sales Market Share by Type (2016-2026)
Figure 69. South America Daclatasvir Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Daclatasvir Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Daclatasvir Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Daclatasvir Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Daclatasvir Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
C型肝炎ウイルスと治療薬の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma. Hepatitis C virus (HCV) is the leading cause of end-stage liver disease and hepatocellular carcinoma Scope of the Report: This report studies the Hepatitis C Virus And Therapeutics market status and…- 抗C型肝炎ウイルスの世界市場2018-2025 Hepatitis C is a contagious liver disease caused due to hepatitis C virus. Hepatitis C damages and infects the liver. Hepatitis C is spread as the infected blood comes in contact with non-infected blood. Ranging in severity hepatitis C can cause acute and chronic hepatitis infection. Chronic hepatit…
- 世界のソフォスブビル/レジパスビル配合薬市場 2021：企業別、地域別、種類・用途別 The Sofosbuvir/Ledipasvir Compound Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …
- 腫瘍崩壊性ウイルス免疫療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Oncology Immunotherapy exploits virus's ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus …
- 世界の単純ヘルペスウイルス（HSV）ワクチン市場 2021：企業別、地域別、種類・用途別 The Herpes Simplex Virus (HSV) Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, t…